• Editor-in-Chief

    Nicola Normanno, MD

    Scientific Director, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy
    Email: nicnorm@yahoo.com
    Founding Editor-in-Chief

    Graham Packham, PhD

    Professor of Molecular Oncology, University of Southampton, Southampton, UK
    Associate Editors

    Francesco Bertoni, MD

    Interests: lymphoma; novel drugs; genomics; BET; PI3K
    Head, Lymphoma Genomics, Deputy Director, Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland

    Giovanni Blandino, MD

    Interests: tumor suppressors; non-coding RNA; Hippo pathway; PI3K inhibitors; HNSCC
    Head of Oncogenomic and Epigenetic Unit, Translation Research Coordinator CTC IFO/IRE, Regina Elena Cancer Institute, Rome, Italy

    Salem Chouaib, PhD

    Interests: cancer immunotherapy; Killer cells; tumor microenvironment; hypoxia; cancer immunology
    INSERM UMR 1186, Integrative Tumour Immunology and Immunotherapy, Gustave Roussy, Fac. de Médecine - Univ. Paris-Sud, Université Paris-Saclay, 94805, Villejuif, France; Thumbay Research Institute for Precision Medicine, Gulf Medical University, Ajman, United Arab Emirates

    Giuseppe Curigliano, MD, PhD

    Interests: breast cancer; early drug development; precision oncology; biomarkers; NGS
    Associate Professor of Medical Oncology, University of Milan; Head, Division of Early Drug Development, European Institute of Oncology, Milan, Italy

    Gennaro Daniele, MD, PhD

    Interests: drug development; clinical trials; translational research; gynecologic malignancies; biomarkers
    Scientific Director, Clinical Trials Center, Agostino Gemelli University Policlinic, Rome, Italy

    Massimo Di Maio, MD

    Interests: clinical trials; meta-analysis; patient-reported outcomes; methodology; quality of life
    Director, Division of Medical Oncology, A.O. Ordine Mauriziano; Associate Professor of Medical Oncology, Department of Oncology, University of Turin, Torino, Italy

    Jianxun Ding, PhD

    Interests: polymer chemistry; biomaterial; controlled drug delivery; immunotherapy; regenerative medicine
    Associate Professor, Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, China

    A. Ganesan, PhD

    Interests: medicinal chemistry; chemical biology; organic synthesis; epigenetics; natural products
    Professor in Chemical Biology, School of Pharmacy, University of East Anglia, Norwich, UK

    Jesus Garcia-Foncillas, PhD, MD

    Interests: colorectal cancer; biomarkers; gastrointestinal cancer; translational oncology
    Full professsor of Oncology, School of Medicine and Director, Cancer Institute, University Hospital Fundacion Jimenez Diaz, Oncohealth Institute, Autonomous University, Madrid, Spain

    Alexandros Georgakilas, PhD

    Interests: DNA damage and repair; radiation biology; biological consequences of radiations; biophysics; bioinformatics; systems biology; tumor suppressors
    Head of DNA Damage Laboratory, Physics Department, School of Applied Mathematical and Physical Sciences, National Technical University of Athens (NTUA), Athens 15780, Greece

    Antonio Giordano, MD, PhD

    Interests: genetics; molecular biology; pathology; oncology; environment
    Present Professor, Department of Biology and Medicine; Present Director, Sbarro Health Research Organization; Present Director, Center of Biotechnology; Present Director, Professional Master Program (PSM) in Bioinnovation; Temple University, Philadelphia, PA, USA. Present “Chiara Fama” Professor, Department of Medical Biotechnology, University of Siena, Siena, Italy

    Marius Ilié, MD, PhD

    Interests: pathology; lung cancer; biomarkers; liquid biopsy; precision pathology
    Professor of Pathology, Université Côte d'Azur; Surgical Pathologist, Nice University Hospital, Nice, France

    Chunsheng Kang, MD, PhD

    Interests: nano-medicine; signaling pathways; exosome and endocytosis; gene editing; neuro-oncology
    Deputy Director of Tianjin Neurology Institute, Director of Neuro-tumor Laboratory of Tianjin Medical University General Hospital, Tianjin, China

    Simon Langdon, MA, PhD

    Interests: ovarian cancer; breast cancer; estrogen signaling; HER signaling; DNA repair
    Reader, School of Medicine, University of Edinburgh, Edinburgh, UK

    Wanliang Lu, PhD

    Interests: resistant cancer; cancer stem cells; gene regulation; nanomaterials; liposomes
    Professor and Vice Dean, School of Pharmaceutical Sciences, Peking University, Beijing, China

    Maurie Markman, MD

    Interests: ovarian cancer; gynecologic malignancies; endometrial cancer, cervix cancer; targeted therapeutics
    President, Cancer Treatment Centers of America Medicine & Science; Chief Clinical Officer, CTCA Health, Philadelphia, PA, USA

    Erika Martinelli, MD, PhD

    Interests: colorectal cancer; translational research; resistance to targeted therapies; gastrointestinal cancer
    Associate Professor in Medical Oncology, Department of Precision Medicine, Università degli Studi della Campania "Luigi Vanvitelli", Naples, Italy

    Alessandro Morabito, MD

    Interests: lung cancer; target based agents; angiogenesis inhibitors; immunotherapy; clinical trials
    Director of Thoracic Medical Oncology, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Naples, Italy

    Athanasios G. Papavassiliou, M.D, Ph.D

    Interests: signal transduction to transcription factors in solid tumors; cancer mechanobiology
    Professor of Biochemistry and Head of the Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, Greece

    Godefridus J. (Frits) Peters, Ph.D

    Interests: cancer biomarkers; apoptosis; lung diseases; cell culture; gene expression; pharmacokinetics; pharmacodynamics; pharmacogenetics of anticancer drugs; gastrointestinal cancers; translational research
    Professor of Pharmacology of cytostatics, Laboratory Medical Oncology, Amsterdam UMC, location VUMC, CCA, Netherlands; Professor at Department of Biochemistry, Medical University of Gdansk, Poland

    Arun Seth, PhD

    Interests: precision oncology; breast and prostate cancer biology; molecular diagnostics; genomic profiling; next-generation sequencing; targeted cancer therapy
    Scientific Director of Molecular Diagnostics, Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre; Academic Director, Genomics Core Facility, Senior Scientist, Sunnybrook Research Institute; Professor, Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, Canada

    Gautam Sethi, PhD

    Interests: signal transduction; apoptosis; transcription factors; metastasis; mouse models of cancer
    Associate Professor, Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore City, Singapore

    Gareth J. Thomas, PhD

    Interests: tumour microenvironment; tumor immunology; head and neck cancer; pathology; fibroblasts
    Professor of Experimental Pathology, Consultant in Histopathology, University of Southampton, Southampton, UK
    Editorial Board Members

    Luca Agnelli, PhD

    Interests: lymphoid malignancies; bioinformatics and biostatistics in cancer; -omics analyses; NGS; non-coding RNA
    Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy

    Matthias Baud, PhD

    Interests: chemical biology; medicinal chemistry; small molecule; organic synthesis
    Lecturer in Medicinal Chemistry and Chemical Biology, University of Southampton, Southampton, UK

    Rossana Berardi, MD

    Interests: thoracic cancer; breast cancer; neuroendocrine tumors; innovative therapies; COVID-19 and cancer
    Professor in Medical Oncology and Director of the Postgraduate School of Medical Oncology at Università Politecnica Marche; Director of Department of Medical Oncology, Director of “Genetic Cancer” Center and Breast Unit Coordinator at Ospedali Riuniti of Ancona, Ancona, Italy

    George A. Calin, MD, PhD

    Interests: microRNA; non-codingRNA; cancer; therapy; biomarkers; genomics
    Professor, Department of Translational Molecular Pathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, US; Co-Director, The RNA Interference and non-codingRNA Center, The University of Texas MD Anderson Cancer Center, Houston, US; Co-Director, MD/PhD Program, The University of Texas, Graduate School of Biomedical Sciences, Houston, US

    Angela Celetti, MD, PhD

    Interests: tumor suppresor genes; biomarkers; DNA damage response and repair; synthetic lethality; poly(ADP-ribose) polymerases (PARPs) inhibitors
    Senior Staff Scientist, Institute of Experimental Endocrinology and Oncology "G. Salvatore" (IEOS), National Research Council (CNR), Naples, Italy

    Laura Cerchia, PhD

    Interests: aptamers; cell-SELEX; cancer theranostics; cell-surface receptors; tumor‐targeted drug delivery
    Research Scientist, Group Leader, Institute of Experimental Endocrinology and Oncology "G. Salvatore" (IEOS), National Research Council (CNR), Naples, Italy

    Fortunato Ciardiello, MD, PhD

    Interests: EGFR positive lung cancer; familial colorectal cancer; lung cancer; non-small cell lung cancer
    Full Professor of Medical Oncology, Director of the Division of Medical Oncology, Dean of the School of Medicine and Surgery, University of Campania Luigi Vanvitelli, Naples, Italy

    Mark Cragg, PhD

    Interests: antibody immunotherapy; apoptosis; Fc gamma receptors; TNF RECEPTORS; CD20
    Professor of Experimental Cancer Research, Director of Cancer Pathway Integrated Postgraduate Programme, University of Southampton, Southampton, UK

    Donatella Del Bufalo, PhD

    Interests: melanoma; angiogenesis; bcl-2 family; tumor progression; target therapy
    Senior investigator, Preclinical Models and New Therapeutic Agents Unit, Translational Research Functional Departmental Area, Regina Elena National Cancer Institute, Rome, Italy

    Eyad Elkord, PhD

    Interests: tumor immunology; cancer immunotherapy; immunosuppression; T regulatory cells; immune checkpoints; cancer epigenetics
    Professor, Department of Applied Biology, College of Science, University of Sharjah, Sharjah, United Arab Emirates; Honorary Professor, Biomedical Research Center, School of Science, Engineering and Environment, University of Salford, Manchester, UK